NAT-APIXABAN

natco pharma (canada) inc🇨🇦 Health Canada

Approval Id: d94baf7e40ad0115
Drug Approval Canada Name: NAT-APIXABAN
Product Name: NAT-APIXABAN
Status: Marketed
Status Date: 2022-09-21
Original Market Date: 2022-09-21
Din: 02492814
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 20:12.04.14
Atc Original: B01AF02 APIXABAN
Atc Name: b 01 af 02
Aig Number: 0153051001
Company Name: natco pharma (canada) inc
Company Address: 2000 Argentia Road, Plaza 1, Suite 200, Mississauga, Ontario, Canada, L5N 1P7

APIXABAN

2.5 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

d94baf7e40ad0115

Type

Standard